See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: May 19, 2008

Systemic Lupus Erythematosus Post Menopause Breast Cancer

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Systemic Lupus Erythematosus

If you are a SL0007 patient who completed week eight of the study or later, you may qualify to participate in this new study.

The research site is in Oklahoma City, Okla.

More information

Please see


Post Menopause

If you are 50 or older, postmenopausal, and have a lack of sexual desire, you may qualify for this study of an investigational drug.

The research site is in Charlottesville, Va.

More information

Please see


Breast Cancer

If you are at least 18, have been diagnosed with HER2-positive metastatic breast cancer, and are eligible for chemotherapy, you may qualify for this study.

The research site is in Pittsburgh, Penn.

More information

Please see


Copyright 2008 Thomson CenterWatch. All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.